Loading...
PhD Katarina Žnidar

PhD Katarina Žnidar
no.: 37534 source: ARIS

researcher – active in research organisation
Research activity

Code Science Field Subfield
3.00.00  Medical sciences     
3.04.00  Medical sciences  Oncology   
Bibliography Representative bibliographic units | Personal | COBISS+
source: COBISS
source: SICRIS
Points
124.55
A''
0
A'
116.62
A1/2
116.62
CI10
194
CImax
35
h10
8
A1
0.49
A3
1.33
Data for the last 5 years (citations for the last 10 years) on October 15, 2025; Data for score A3 calculation refer to period 2020-2024 (2022, 2023)
Data for ARIS tenders ( 23.05.2022 – Target research programmes, archive )
Database Linked records Citations Pure citations Average pure citations
WoS 17  232  155  9.12 
Scopus 15  274  191  12.73 
Doctoral dissertations and other final papers Show
Obtaining results now
source: COBISS
Employments
source: ARIS
Type of employment Research org. Research group
Full time employment (100%, RD:100%)  Institute of Oncology Ljubljana  Department of research 
Research projects Legend
source: ARIS
no. Code Title Period Head No. of publications
1. J3-60068  Circulating tumor cell translational research platform.   1/1/2025 - 12/31/2027  PhD Tanja Jesenko   2,923 
2. J1-60017  Perfusion, Edema, and Necrosis Evaluation using OCT for Tumor Outcome Measures   1/1/2025 - 12/31/2027  PhD Jošt Stergar   2,743 
3. J3-50108  DEBIO 1143 has a potential to increase effectiveness of electrochemotherapy and radiotherapy in HPV positive and HPV negative Head and Neck Cancers   10/1/2023 - 9/30/2026  PhD Katarina Žnidar   2,397 
4. J4-50150  Erythrocyte membrane-based nanocarriers for gene silencing cancer therapy   10/1/2023 - 9/30/2026  PhD Nina Kostevšek   4,220 
5. L3-50111  Gene immuno-therapy of solid tumors based on mRNA encoding interleukin-12: So-rIL   10/1/2023 - 9/30/2026  PhD Maja Čemažar   3,048 
6. J3-50110  Intratumoral mRNA electrotransfer: establishment and preclinical proof of concept   10/1/2023 - 9/30/2026  PhD Katja Uršič Valentinuzzi   3,367 
7. J2-50068  Safety and efficacy of high frequency electrochemotherapy - clinical device development   10/1/2023 - 9/30/2026  PhD Matej Reberšek   3,729 
8. J7-50128  Trace metals disorder as biomarker in biliary tract cancers   10/1/2023 - 9/30/2026  PhD Janez Ščančar   3,939 
9. J7-4635  MitoCan - Preclinical development of new Mitochondrial ion channel inhibitors for Cancer therapy   10/1/2022 - 9/30/2026  PhD Lucija Peterlin Mašič   6,640 
10. L7-4491  Development of integrated multi-channel artificial nose for detection of cancer   10/1/2022 - 9/30/2025  PhD Igor Muševič   5,928 
11. J1-4417  Development of novel small molecule Toll-like receptors 7 and 8 modulators for cancer immunotherapy   10/1/2022 - 9/30/2025  PhD Matej Sova   4,257 
12. J3-4504  Uncovering the glioblastoma microenvironment to enhance the therapy   10/1/2022 - 9/30/2025  PhD Metka Novak   1,982 
13. J3-3083  Vascularization and vascular effects as predictive factors for local ablative techniques   10/1/2021 - 9/30/2025  PhD Gregor Serša   7,319 
14. J3-3084  Inducible Programming of CAR T Cell Intrinsic Properties for Cancer Immunotherapy   10/1/2021 - 12/31/2024  PhD Anže Smole   2,851 
15. J3-2529  Role of endothelium in tumor response to radiotherapy   9/1/2020 - 8/31/2023  PhD Boštjan Markelc   3,723 
ARIS research and infrastructure programmes Legend
source: ARIS
no. Code Title Period Head No. of publications
1. P3-0428  Comparative oncology for tackling rare cancers   1/1/2022 - 12/31/2027 PhD Ario de Marco   1,038 
2. P3-0003  Development and evaluation of new approaches to cancer treatment   1/1/2015 - 12/31/2021 PhD Gregor Serša   3,528 
3. P3-0003  Development and evaluation of new approaches to cancer treatment   1/1/2009 - 12/31/2014 PhD Gregor Serša   4,296 
We were not given permission by the researcher to publish data.
Views history
Favourite